Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

CBA share price: Where next following Q1 FY21 trading update?

We examine the highlights from CBA’s latest quarterly report as well as look at what two key brokers currently think of the bank’s prospects.

CBA share price: Where next following Q1 FY21 trading update? Source: Bloomberg

CBA share price: The Q1 FY21 update at a glance

During the first quarter of fiscal 2021 the Commonwealth Bank of Australia (CBA) saw its capital position improve, profits dip and lending volumes increase across the board. The stock traded flatly in response to this update and remains down close to 7% YTD, from yesterday’s closing price.

CBA opened at $74.40 per share on Thursday, November 12.

Overall, CBA reported unaudited statutory profits (NPAT) of $1.9 billion against unaudited cash profits (NPAT) of $1.8 billion, down 16%. Despite a challenging operating environment the bank reported stable net interest income, with volume growth across its loan books offsetting the impact of lower margins.

The bank said this was driven by 'reduced earnings on deposits and capital from lower interest rates, unfavourable lending margins [as well as] higher liquid assets.’

CBA continues to build out its position as the biggest of the big four, reporting volume growth across all of its key loan portfolios: Home lending rose $5.6 billion (2x system), household deposits gained $15.8 billion (>1x system) and business lending rose $1.4 billion (>2x system).

Elsewhere, operating expenses fell 4% during the quarter.

Credit quality to remain in focus

The coronavirus and its economic impact – both broadly and on an individual level continues to be a key overhang for the bank, with total credit provisioning rising to $6.7 billion during the quarter, while troublesome and impaired assets dipped to $8.4 billion. This movement lower, said CBA 'mainly reflects lower home loan impairments due to ongoing COVID-19 support.’

Despite a ‘large number’ of loan deferrals expiring in September and October, by October 31, the bank noted that some 46,000 home loans, totalling $19 billion, remain in a state of deferral. Though those figures remain elevated, they've come down significantly from June, where total loan balances in deferral stood at $49 billion.

'We continue to contact customers with a range of options as they approach the end of temporary loan repayment deferral periods, and have been encouraged by the number of customers who have been able to return to making payments on their loans.'

Finally, CBA continues to tout a strong capital position, reporting a CET1 ratio of 11.8% by the close of the September quarter – firmly above APRA’s ‘unquestionably strong’ requirements.

Where next? The analyst outlook

Looking ahead, analysts from Macquarie Wealth Management upgraded their price target from $58.50 to $65.00 per share following the bank’s Q1. Ultimately, with CBA trading at a significant premium to its peers, Macquarie analysts said 'We believe this premium should narrow in a low rate environment and we maintain Underperform recommendation.’

By comparison, analysts from Credit Suisse appeared somewhat more constructive on CBA’s outlook noting that while the Q1 was 'slightly underwhelming', looking forward 'we expect the sector to benefit from recovery status and within this CBA’s defensive status is likely to see it lag peer share price recovery.’

Credit Suisse has a price target of $74.80 per share and a Neutral rating on CBA.

Want to take a position in CBA – long or short?

Create an IG trading account or log in to your existing account to get started now.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Tuesday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.